Delap Wealth Advisory’s CVS Health CVS Stock Holding History

Delap Wealth Advisory’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,993	Closed	-$717K	–	166
2024 Q1	$717K	Buy	+8,993	New	+$687K	0.29%	52

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Delap Wealth Advisory's CVS Position: Q2 2024 in Review

Delap Wealth Advisory sold out of CVS Health (CVS) in Q2 2024, closing a stake of 8,993 shares — an estimated $717K sold.

Delap Wealth Advisory first reported a position in CVS in Q1 2024 and held it in 1 quarter. The position peaked at $717K in Q1 2024. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Delap Wealth Advisory reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Delap Wealth Advisory sold 8,993 CVS Health shares in Q2 2024, an estimated $717K.
Delap Wealth Advisory first reported a position in CVS Health in Q1 2024 and held it in 1 quarter.
Delap Wealth Advisory's CVS Health position peaked at $717K in Q1 2024.
1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Delap Wealth Advisory's 13F filing for Q2 2024, filed 13 Aug 2024.